151 related articles for article (PubMed ID: 16131524)
21. [Properties of metlegoglobin reductase from lupin root nodules].
Topunov AF; Melik-Sarkisian SS; Lysenko LA; Kretovich VL
Biokhimiia; 1982 Mar; 47(3):442-6. PubMed ID: 7074171
[TBL] [Abstract][Full Text] [Related]
22. Role of carboxyl residues surrounding heme of human cytochrome b5 in the electrostatic interaction with NADH-cytochrome b5 reductase.
Kawano M; Shirabe K; Nagai T; Takeshita M
Biochem Biophys Res Commun; 1998 Apr; 245(3):666-9. PubMed ID: 9588172
[TBL] [Abstract][Full Text] [Related]
23. Characterizing the fragmentation of 2,5-bis (4-amidinophenyl)furan-bis-O-methylamidoxime and selected metabolites using ion trap mass spectrometry.
Zhou L; Voyksner RD; Thakker DR; Stephens CE; Anbazhagan M; Boykin DW; Hall JE; Tidwell RR
Rapid Commun Mass Spectrom; 2002; 16(11):1078-85. PubMed ID: 11992511
[TBL] [Abstract][Full Text] [Related]
24. Reduction of Nomega-hydroxy-L-arginine to L-arginine by pig liver microsomes, mitochondria, and human liver microsomes.
Clement B; Kunze T; Heberling S
Biochem Biophys Res Commun; 2006 Oct; 349(2):869-73. PubMed ID: 16959215
[TBL] [Abstract][Full Text] [Related]
25. Effect of divalent cations on NADH-dependent and NADPH-dependent cytochrome b5 reduction by hepatic microsomes.
Tamura M; Yoshida S; Tamura T; Saitoh T; Takeshita M
Arch Biochem Biophys; 1990 Aug; 280(2):313-9. PubMed ID: 2369123
[TBL] [Abstract][Full Text] [Related]
26. In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis.
Ansede JH; Voyksner RD; Ismail MA; Boykin DW; Tidwell RR; Hall JE
Xenobiotica; 2005 Mar; 35(3):211-26. PubMed ID: 16019947
[TBL] [Abstract][Full Text] [Related]
27. In vitro effects of myricetin, morin, apigenin, (+)-taxifolin, (+)-catechin, (-)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 reductase.
Çelik H; Koşar M; Arinç E
Toxicology; 2013 Jun; 308():34-40. PubMed ID: 23567315
[TBL] [Abstract][Full Text] [Related]
28. The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice.
Jakobs HH; Mikula M; Havemeyer A; Strzalkowska A; Borowa-Chmielak M; Dzwonek A; Gajewska M; Hennig EE; Ostrowski J; Clement B
PLoS One; 2014; 9(8):e105371. PubMed ID: 25144769
[TBL] [Abstract][Full Text] [Related]
29. Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.
Kurian JR; Chin NA; Longlais BJ; Hayes KL; Trepanier LA
Chem Res Toxicol; 2006 Oct; 19(10):1366-73. PubMed ID: 17040106
[TBL] [Abstract][Full Text] [Related]
30. Defining the Role of the NADH-Cytochrome-b5 Reductase 3 in the Mitochondrial Amidoxime Reducing Component Enzyme System.
Plitzko B; Havemeyer A; Bork B; Bittner F; Mendel R; Clement B
Drug Metab Dispos; 2016 Oct; 44(10):1617-21. PubMed ID: 27469001
[TBL] [Abstract][Full Text] [Related]
31. Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue.
Sturk LM; Brock JL; Bagnell CR; Hall JE; Tidwell RR
Acta Trop; 2004 Jul; 91(2):131-43. PubMed ID: 15234662
[TBL] [Abstract][Full Text] [Related]
32. Mutagenesis of Glycine 179 modulates both catalytic efficiency and reduced pyridine nucleotide specificity in cytochrome b5 reductase.
Roma GW; Crowley LJ; Davis CA; Barber MJ
Biochemistry; 2005 Oct; 44(41):13467-76. PubMed ID: 16216070
[TBL] [Abstract][Full Text] [Related]
33. Purification and partial characterization of microsomal NADH-cytochrome b5 reductase from higher plant Catharanthus roseus.
Madyastha KM; Chary NK; Holla R; Karegowdar TB
Biochem Biophys Res Commun; 1993 Dec; 197(2):518-22. PubMed ID: 8267585
[TBL] [Abstract][Full Text] [Related]
34. NADH- and NADPH-dependent reconstituted p-nitroanisole O-demethylation system containing cytochrome P-450 with high affinity for cytochrome b5.
Sugiyama T; Miki N; Yamano T
J Biochem; 1980 May; 87(5):1457-67. PubMed ID: 7390994
[TBL] [Abstract][Full Text] [Related]
35. The roles of cytochrome b5 in cytochrome P450 reactions.
Porter TD
J Biochem Mol Toxicol; 2002; 16(6):311-6. PubMed ID: 12481306
[TBL] [Abstract][Full Text] [Related]
36. Generation of reactive oxygen species during mouse hepatic microsomal metabolism of cannabidiol and cannabidiol hydroxy-quinone.
Usami N; Yamamoto I; Watanabe K
Life Sci; 2008 Nov; 83(21-22):717-24. PubMed ID: 18929579
[TBL] [Abstract][Full Text] [Related]
37. The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs.
Gruenewald S; Wahl B; Bittner F; Hungeling H; Kanzow S; Kotthaus J; Schwering U; Mendel RR; Clement B
J Med Chem; 2008 Dec; 51(24):8173-7. PubMed ID: 19053771
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4.
Celik H; Arinç E
Xenobiotica; 2013 Mar; 43(3):263-75. PubMed ID: 22928801
[TBL] [Abstract][Full Text] [Related]
39. Identification of cytochrome-b5 reductase as the enzyme responsible for NADH-dependent lucigenin chemiluminescence in human spermatozoa.
Baker MA; Krutskikh A; Curry BJ; Hetherington L; Aitken RJ
Biol Reprod; 2005 Aug; 73(2):334-42. PubMed ID: 15858218
[TBL] [Abstract][Full Text] [Related]
40. Characterization of diuron N-demethylation by mammalian hepatic microsomes and cDNA-expressed human cytochrome P450 enzymes.
Abass K; Reponen P; Turpeinen M; Jalonen J; Pelkonen O
Drug Metab Dispos; 2007 Sep; 35(9):1634-41. PubMed ID: 17576805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
